Kolon Life Science Inc (102940) - Total Liabilities

Latest as of September 2025: ₩295.72 Billion KRW ≈ $200.41 Million USD

Based on the latest financial reports, Kolon Life Science Inc (102940) has total liabilities worth ₩295.72 Billion KRW (≈ $200.41 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 102940 long-term investments to assets to see how much of total assets are deployed in long-term investments.

Kolon Life Science Inc - Total Liabilities Trend (2014–2024)

This chart illustrates how Kolon Life Science Inc's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see 102940 total assets.

Kolon Life Science Inc Competitors by Total Liabilities

The table below lists competitors of Kolon Life Science Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Answear.com S.A. WAR:ANR	Poland	zł628.64 Million
Excel Cell Electronic Co Ltd TW:2483	Taiwan	NT$1.64 Billion
Tesoro Gold Ltd AU:TSO	Australia	AU$1.85 Million
SynAct Pharma AB ST:SYNACT	Sweden	Skr44.13 Million
Coya Therapeutics, Inc. Common Stock NASDAQ:COYA	USA	$4.03 Billion
Seoyon Co Ltd KO:007860	Korea	₩2.05 Trillion
K N Kenanga Holdings Bhd KLSE:6483	Malaysia	RM6.03 Billion
GaeaSoft Corp KQ:051160	Korea	₩90.81 Billion

Liability Composition Analysis (2014–2024)

This chart breaks down Kolon Life Science Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Kolon Life Science Inc balance sheet quality to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.56	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.85	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.46	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Kolon Life Science Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Kolon Life Science Inc (2014–2024)

The table below shows the annual total liabilities of Kolon Life Science Inc from 2014 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩270.23 Billion ≈ $183.13 Million	+57.32%
2023-12-31	₩171.76 Billion ≈ $116.40 Million	+17.33%
2022-12-31	₩146.39 Billion ≈ $99.21 Million	+8.24%
2021-12-31	₩135.25 Billion ≈ $91.66 Million	-28.96%
2020-12-31	₩190.38 Billion ≈ $129.02 Million	+7.39%
2019-12-31	₩177.27 Billion ≈ $120.14 Million	+2.61%
2018-12-31	₩172.76 Billion ≈ $117.08 Million	+0.80%
2017-12-31	₩171.38 Billion ≈ $116.14 Million	+80.81%
2016-12-31	₩94.78 Billion ≈ $64.23 Million	+1.73%
2015-12-31	₩93.17 Billion ≈ $63.14 Million	+28.13%
2014-12-31	₩72.72 Billion ≈ $49.28 Million	--

About Kolon Life Science Inc

KQ:102940 Korea Pharmaceuticals

Market Cap

$109.55 Million

₩161.65 Billion KRW

Market Cap Rank

#18948 Global

#900 in Korea

Share Price

₩14170.00

Change (1 day)

+0.85%

52-Week Range

₩13300.00 - ₩70800.00

All Time High

₩163572.85